News about Global Pharma

Sionna Signs License Agreement with AbbVie for Clinical Stage Compounds

Sionna Therapeutics has secured exclusive worldwide rights to develop and commercialize multiple clinical-stage compounds through a license agreement with AbbVie.

Global Pharma | 30/07/2024 | By Aishwarya |  651

Strides Pharma Shows Strong Q1FY25 Results with 16.7 Percent of Revenue Growth

Strides Pharma Science Ltd. has announced its consolidated financial results for the quarter (Q1FY25).

Global Pharma | 29/07/2024 | By Aishwarya |  811

Lifrblood Picks Brooks PathFinder System for Sample Management

Brooks Automation has been appointed as an official vendor for Lifeblood (Australian Red Cross Lifeblood), a global organization dedicated to the supply of blood and blood products.

Global Pharma | 29/07/2024 | By Aishwarya |  487

Acumen Announces New Findings from Phase 1 INTERCEPT-AD Study at AAIC 2024

Acumen Pharmaceuticals, Inc. has published new findings from its Phase 1 INTERCEPT-AD study of sabirnetug (ACU193).

Global Pharma | 29/07/2024 | By Aishwarya |  645

Emcure Pharma Signs PPA with Sunsure Energy to Boost its Sustainability Initiatives

Emcure Pharmaceuticals Ltd. has signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, one of India's leading renewable power producers.

Global Pharma | 26/07/2024 | By Aishwarya |  1234

Mankind Pharma to Acquire Bharat Serums and Vaccines

Mankind Pharma has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Ltd. (BSV) from Advent International, for an enterprise value of approx. INR 13,630 Crores, subject to closing-related adjustments.

Global Pharma | 26/07/2024 | By Aishwarya |  964

Merck Signs MoU with Gene Therapy Research Institution

Merck has signed a non-binding Memorandum of Understanding (MoU) with Gene Therapy Research Institution Co., Ltd. (GTRI), a Japanese clinical-stage biotech start-up specializing in gene therapy using adeno-associated virus (AAV) vectors.

Global Pharma | 25/07/2024 | By Aishwarya |  713

Alembic Pharma Received FDA Approval for Fluphenazine Hydrochloride Tablets

Alembic Pharmaceuticals Ltd. has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg.

Global Pharma | 25/07/2024 | By Aishwarya |  882

Ceryx Medical Gets Trial Approval for New Pacemaker from MHRA

Ceryx Medical has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot RSA-pace study of the Cysoni-XT system for post-cardiac surgery patients.

Global Pharma | 24/07/2024 | By Aishwarya |  669

Gland Pharma Gets Tentative Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution

Gland Pharma Ltd. has secured tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024 percent.

Global Pharma | 24/07/2024 | By Aishwarya |  821